EE200000742A - Karnitiini ning inositoolfosfaati sisaldav kompositsioon toidulisandi või ravimina - Google Patents

Karnitiini ning inositoolfosfaati sisaldav kompositsioon toidulisandi või ravimina

Info

Publication number
EE200000742A
EE200000742A EEP200000742A EEP200000742A EE200000742A EE 200000742 A EE200000742 A EE 200000742A EE P200000742 A EEP200000742 A EE P200000742A EE P200000742 A EEP200000742 A EE P200000742A EE 200000742 A EE200000742 A EE 200000742A
Authority
EE
Estonia
Prior art keywords
carnitine
medicament
composition
dietary supplement
inositol phosphate
Prior art date
Application number
EEP200000742A
Other languages
English (en)
Estonian (et)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of EE200000742A publication Critical patent/EE200000742A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
EEP200000742A 1999-04-22 2000-04-19 Karnitiini ning inositoolfosfaati sisaldav kompositsioon toidulisandi või ravimina EE200000742A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000248A IT1306133B1 (it) 1999-04-22 1999-04-22 Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
PCT/IT2000/000158 WO2000064426A2 (en) 1999-04-22 2000-04-19 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Publications (1)

Publication Number Publication Date
EE200000742A true EE200000742A (et) 2002-04-15

Family

ID=11406708

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000742A EE200000742A (et) 1999-04-22 2000-04-19 Karnitiini ning inositoolfosfaati sisaldav kompositsioon toidulisandi või ravimina

Country Status (26)

Country Link
US (1) US6565876B1 (pl)
EP (1) EP1119363B1 (pl)
JP (1) JP2002542282A (pl)
KR (1) KR20010053023A (pl)
CN (1) CN1359295A (pl)
AR (1) AR023391A1 (pl)
AT (1) ATE299370T1 (pl)
AU (1) AU776591B2 (pl)
BR (1) BR0006076A (pl)
CA (1) CA2335015C (pl)
DE (1) DE60021247T2 (pl)
DK (1) DK1119363T3 (pl)
EE (1) EE200000742A (pl)
ES (1) ES2243254T3 (pl)
HU (1) HU227357B1 (pl)
IL (1) IL140164A0 (pl)
IS (1) IS5763A (pl)
IT (1) IT1306133B1 (pl)
NO (1) NO20006429L (pl)
PL (1) PL197885B1 (pl)
PT (1) PT1119363E (pl)
SI (1) SI1119363T1 (pl)
SK (1) SK19322000A3 (pl)
TN (1) TNSN00083A1 (pl)
TR (1) TR200003737T1 (pl)
WO (1) WO2000064426A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
WO2006102060A1 (en) * 2005-03-18 2006-09-28 Oxyplus, Inc. Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.
JP5281268B2 (ja) * 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
JP2012508267A (ja) * 2008-11-11 2012-04-05 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ セルライトの処置に有用な化合物
EP2582368B1 (en) * 2010-06-16 2018-05-09 Alfasigma S.p.A. Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
ES2495666B1 (es) * 2013-03-15 2015-08-10 Laboratoris Sanifit, S.L. Uso de derivados con enlaces c-o-p en pacientes con fallo renal
KR102141971B1 (ko) * 2018-11-12 2020-08-06 주식회사 노암 항암용 조성물
TW202110437A (zh) * 2019-05-23 2021-03-16 美商希諾瓦有限責任公司 用於酒精誘發之皮膚潮紅之治療及緩解的組成物及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
EP1021177A4 (en) * 1997-02-04 2002-05-15 John V Kosbab COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF VASCULAR DEGENERATIVE DISEASES
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition

Also Published As

Publication number Publication date
US6565876B1 (en) 2003-05-20
AR023391A1 (es) 2002-09-04
SI1119363T1 (en) 2005-10-31
CA2335015A1 (en) 2000-11-02
NO20006429L (no) 2001-02-20
BR0006076A (pt) 2001-03-20
AU776591B2 (en) 2004-09-16
JP2002542282A (ja) 2002-12-10
ATE299370T1 (de) 2005-07-15
DE60021247T2 (de) 2006-04-27
PL197885B1 (pl) 2008-05-30
ES2243254T3 (es) 2005-12-01
HUP0102926A2 (hu) 2002-03-28
IT1306133B1 (it) 2001-05-30
EP1119363A2 (en) 2001-08-01
HUP0102926A3 (en) 2002-12-28
SK19322000A3 (sk) 2001-06-11
ITRM990248A1 (it) 2000-10-22
KR20010053023A (ko) 2001-06-25
DE60021247D1 (de) 2005-08-18
NO20006429D0 (no) 2000-12-15
IS5763A (is) 2000-12-08
DK1119363T3 (da) 2005-10-17
AU4313500A (en) 2000-11-10
TNSN00083A1 (fr) 2005-11-10
EP1119363B1 (en) 2005-07-13
TR200003737T1 (tr) 2001-07-23
PT1119363E (pt) 2005-09-30
WO2000064426A2 (en) 2000-11-02
IL140164A0 (en) 2002-02-10
CN1359295A (zh) 2002-07-17
CA2335015C (en) 2008-03-18
PL346160A1 (en) 2002-01-28
WO2000064426A3 (en) 2001-05-25
HU227357B1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
EE200100618A (et) Dieet- või farmatseutiline kompositsioon kasutamiseks hüperoksaluuria vältimiseks või raviks
GB9916536D0 (en) Nutritional or pharmaceutical compositions
EG24066A (en) Novel quinuclidine derivatives and medicinal compositions containing the same
EP1329456A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZEN DERIVATIVES AND MEDICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
HUP0104195A3 (en) Vitamin d analogues, preparation thereof, pharmaceutical and cosmetic compositions containing them
HUP0103507A2 (hu) 2-Kinolonokat tartalmazó gyógyászati készítmények
PL343627A1 (en) Medicinal compositions
EP1166786A4 (en) MEDICAL COMPOSITIONS
IL140164A0 (en) Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
IL125020A0 (en) Pharmaceutical compositions with vitamin d analogues
EE200100661A (et) Leeliselist sfingomüelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi või farmatseutilise tootena
IL145733A0 (en) A polpyeptide containing an immunogenic portion of a breast protein and pharmaceutical compositions containing the same
IL148807A0 (en) Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
ZA9811655B (en) Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same
GB9820815D0 (en) Improvementsin or relating to nutritional and pharmaceutical compositions
GB9920054D0 (en) Dietary composition
EP1124438A4 (en) Nutritional supplements
IL138994A0 (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same
HUP0200812A3 (en) Vitamin d analogues and their pharmaceutical use
IL133851A0 (en) Dietary supplement
ITMI990597A0 (it) Composizioni farmaceutiche dietetiche o alimenti funzionali ad attivita' antiossidante
ITMI981512A0 (it) Composizioni farmaceutiche dietetiche o alimenti funzionali ad attivita' antiossidante
ATA171599A (de) Pharmazeutische zusammensetzung zur abdeckung des grundbedarfs an vitaminen
IL127102A0 (en) Pharmaceutical compositions for the treatment of dyskinesias